;PMID: 12667489
;source_file_1861.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..47] = [t:0..47]
;1)sentence:[e:53..204] = [t:53..204]
;2)section:[e:208..263] = [t:208..263]
;3)section:[e:267..370] = [t:267..370]
;4)sentence:[e:374..649] = [t:374..649]
;5)sentence:[e:650..761] = [t:650..761]
;6)sentence:[e:762..918] = [t:762..918]
;7)sentence:[e:919..1054] = [t:919..1054]
;8)sentence:[e:1056..1210] = [t:1056..1210]
;9)sentence:[e:1211..1349] = [t:1211..1349]
;10)sentence:[e:1350..1524] = [t:1350..1524]
;11)sentence:[e:1526..1693] = [t:1526..1693]
;12)sentence:[e:1694..1757] = [t:1694..1757]
;13)sentence:[e:1758..1914] = [t:1758..1914]
;14)sentence:[e:1915..2184] = [t:1915..2184]
;15)sentence:[e:2185..2335] = [t:2185..2335]
;16)section:[e:2339..2384] = [t:2339..2384]

;section 0 Span:0..47
;Arch Biochem Biophys. 2003 Apr 15;412(2):251-8.
(SEC
  (FRAG (NNP:[0..4] Arch) (NNP:[5..12] Biochem) (NNP:[13..20] Biophys)
        (.:[20..21] .) (CD:[22..26] 2003) (NNP:[27..30] Apr) (CD:[31..33] 15)
        (CC:[33..38] ;412-LRB-) (CD:[38..39] 2) (-RRB-:[39..40] -RRB-)
        (CD:[40..44] :251) (::[44..45] -) (CD:[45..47] 8.)))

;sentence 1 Span:53..204
;Glucocorticoids inhibit interconversion of 7-hydroxy and 7-oxo metabolites of
; dehydroepiandrosterone: a role for 11beta-hydroxysteroid dehydrogenases?
;[53..68]:substance:"Glucocorticoids"
;[96..105]...[116..127]:substance:"7-hydroxy"..."metabolites"
;[110..127]:substance:"7-oxo metabolites"
;[132..154]:substance:"dehydroepiandrosterone"
;[167..203]:substance:"11beta-hydroxysteroid dehydrogenases"
(SENT
  (FRAG-HLN
    (S
      (NP-SBJ (NNS:[53..68] Glucocorticoids))
      (VP (VBP:[69..76] inhibit)
        (NP
          (NP (NN:[77..92] interconversion))
          (PP (IN:[93..95] of)
            (NP
              (NP
                (NP (JJ:[96..105] 7-hydroxy)
                  (NML-1 (-NONE-:[105..105] *P*)))
                (CC:[106..109] and)
                (NP (JJ:[110..115] 7-oxo)
                  (NML-1 (NNS:[116..127] metabolites))))
              (PP (IN:[128..130] of)
                (NP (NN:[132..154] dehydroepiandrosterone))))))))
    (::[154..155] :)
    (NP
      (NP (DT:[156..157] a) (NN:[158..162] role))
      (PP (IN:[163..166] for)
        (NP (NN:[167..188] 11beta-hydroxysteroid)
            (NNS:[189..203] dehydrogenases)))
      (.:[203..204] ?))))

;section 2 Span:208..263
;Robinzon B, Michael KK, Ripp SL, Winters SJ, Prough RA.
(SEC
  (FRAG (NNP:[208..216] Robinzon) (NNP:[217..218] B) (,:[218..219] ,)
        (NNP:[220..227] Michael) (NNP:[228..230] KK) (,:[230..231] ,)
        (NNP:[232..236] Ripp) (NNP:[237..239] SL) (,:[239..240] ,)
        (NNP:[241..248] Winters) (NNP:[249..251] SJ) (,:[251..252] ,)
        (NNP:[253..259] Prough) (NNP:[260..263] RA.)))

;section 3 Span:267..370
;Department of Biochemistry, University of Louisville Health Science Center, 
;Louisville, KY 40292, USA.
(SEC
  (FRAG (NNP:[267..277] Department) (IN:[278..280] of)
        (NNP:[281..293] Biochemistry) (,:[293..294] ,)
        (NNP:[295..305] University) (IN:[306..308] of)
        (NNP:[309..319] Louisville) (NNP:[320..326] Health)
        (NNP:[327..334] Science) (NNP:[335..341] Center) (,:[341..342] ,)
        (NNP:[344..354] Louisville) (,:[354..355] ,) (NNP:[356..358] KY)
        (CD:[359..364] 40292) (,:[364..365] ,) (NNP:[366..369] USA)
        (.:[369..370] .)))

;sentence 4 Span:374..649
;The cytochrome p450-dependent formation and subsequent interconversion of 
;dehydroepiandrosterone (DHEA) metabolites 7 alpha-hydroxy-DHEA (7 
;alpha-OH-DHEA), 7 beta-hydroxy-DHEA (7 beta-OH-DHEA), and 7-oxo-DHEA was 
;observed in human, pig, and rat liver microsomal fractions.
;[378..393]:cyp450:"cytochrome p450"
;[449..490]:substance:"dehydroepiandrosterone (DHEA) metabolites"
;[491..511]:substance:"7 alpha-hydroxy-DHEA"
;[513..529]:substance:"7  alpha-OH-DHEA"
;[532..551]:substance:"7 beta-hydroxy-DHEA"
;[553..567]:substance:"7 beta-OH-DHEA"
;[574..584]:substance:"7-oxo-DHEA"
(SENT
  (S
    (NP-SBJ-4
      (NP (DT:[374..377] The)
        (NML
          (NML
            (ADJP
              (NML (NN:[378..388] cytochrome) (NN:[389..393] p450))
              (HYPH:[393..394] -) (JJ:[394..403] dependent))
            (NN:[404..413] formation))
          (CC:[414..417] and)
          (NML (JJ:[418..428] subsequent) (NN:[429..444] interconversion))))
      (PP (IN:[445..447] of)
        (NP
          (NP
            (NML
              (NML (NN:[449..471] dehydroepiandrosterone))
              (NP (-LRB-:[472..473] -LRB-) (NN:[473..477] DHEA)
                  (-RRB-:[477..478] -RRB-)))
            (NNS:[479..490] metabolites))
          (NP
            (NP
              (NP (CD:[491..492] 7) (NN:[493..511] alpha-hydroxy-DHEA))
              (NP (-LRB-:[512..513] -LRB-)
                 (CD:[513..514] 7) (NN:[516..529] alpha-OH-DHEA)
                (-RRB-:[529..530] -RRB-)))
            (,:[530..531] ,)
            (NP
              (NP (CD:[532..533] 7) (NN:[534..551] beta-hydroxy-DHEA))
              (NP (-LRB-:[552..553] -LRB-)
                 (CD:[553..554] 7) (NN:[555..567] beta-OH-DHEA)
                (-RRB-:[567..568] -RRB-)))
            (,:[568..569] ,) (CC:[570..573] and)
            (NP (NN:[574..584] 7-oxo-DHEA))))))
    (VP (VBD:[585..588] was)
      (VP (VBN:[590..598] observed)
        (NP-4 (-NONE-:[598..598] *))
        (PP-LOC (IN:[599..601] in)
          (NP
            (NP (JJ:[602..607] human)
              (NML-1 (-NONE-:[607..607] *P*)))
            (,:[607..608] ,)
            (NP (NN:[609..612] pig)
              (NML-1 (-NONE-:[612..612] *P*)))
            (,:[612..613] ,) (CC:[614..617] and)
            (NP (NN:[618..621] rat)
              (NML-1 (NN:[622..627] liver) (JJ:[628..638] microsomal)
                     (NNS:[639..648] fractions)))))))
    (.:[648..649] .)))

;sentence 5 Span:650..761
;Rat liver  mitochondria and nuclei also converted DHEA to 7 alpha-OH-DHEA and
;7-oxo-DHEA,  but at a lower rate.
;[700..704]:substance:"DHEA"
;[708..723]:substance:"7 alpha-OH-DHEA"
;[728..738]:substance:"7-oxo-DHEA"
(SENT
  (S
    (NP-SBJ
      (NP
        (NML-2 (NN:[650..653] Rat) (NN:[654..659] liver))
        (NNS:[661..673] mitochondria))
      (CC:[674..677] and)
      (NP
        (NML-2 (-NONE-:[677..677] *P*))
        (NNS:[678..684] nuclei)))
    (VP
      (VP
        (ADVP (RB:[685..689] also))
        (VBD:[690..699] converted)
        (NP (NN:[700..704] DHEA))
        (PP-CLR (TO:[705..707] to)
          (NP
            (NP (CD:[708..709] 7) (NN:[710..723] alpha-OH-DHEA))
            (CC:[724..727] and)
            (NP (NN:[728..738] 7-oxo-DHEA)))))
      (,:[738..739] ,) (CC:[741..744] but)
      (FRAG
        (PP-MNR (IN:[745..747] at)
          (NP (DT:[748..749] a) (JJR:[750..755] lower) (NN:[756..760] rate)))))
    (.:[760..761] .)))

;sentence 6 Span:762..918
;With NADP(+), and less so with NAD(+), rat, pig, and human  liver microsomes
;and rat liver mitochondria and nuclei converted 7 alpha-OH-DHEA  to
;7-oxo-DHEA.
;[767..774]:substance:"NADP(+)"
;[793..799]:substance:"NAD(+)"
;[887..902]:substance:"7 alpha-OH-DHEA"
;[907..917]:substance:"7-oxo-DHEA"
(SENT
  (S
    (PP
      (PP (IN:[762..766] With)
        (NP (NN:[767..771] NADP) (-LRB-:[771..772] -LRB-) (SYM:[772..773] +)
            (-RRB-:[773..774] -RRB-)))
      (,:[774..775] ,) (CC:[776..779] and)
      (PP
        (ADVP-EXT (RBR:[780..784] less) (RB:[785..787] so))
        (IN:[788..792] with)
        (NP (NN:[793..796] NAD) (-LRB-:[796..797] -LRB-) (SYM:[797..798] +)
            (-RRB-:[798..799] -RRB-))))
    (,:[799..800] ,)
    (NP-SBJ
      (NP
        (NP (NN:[801..804] rat)
          (NML-3 (-NONE-:[804..804] *P*)))
        (,:[804..805] ,)
        (NP (NN:[806..809] pig)
          (NML-3 (-NONE-:[809..809] *P*)))
        (,:[809..810] ,) (CC:[811..814] and)
        (NP (JJ:[815..820] human)
          (NML-3 (NN:[822..827] liver) (NNS:[828..838] microsomes))))
      (CC:[839..842] and)
      (NP
        (NP
          (NML-2 (NN:[843..846] rat))
          (NN:[847..852] liver) (NNS:[853..865] mitochondria))
        (CC:[866..869] and)
        (NP
          (NML-2 (-NONE-:[869..869] *P*))
          (NNS:[870..876] nuclei))))
    (VP (VBD:[877..886] converted)
      (NP (CD:[887..888] 7) (NN:[889..902] alpha-OH-DHEA))
      (PP-CLR (TO:[904..906] to)
        (NP (NN:[907..917] 7-oxo-DHEA))))
    (.:[917..918] .)))

;sentence 7 Span:919..1054
;This reaction was inhibited by corticosterone and the 11  beta-hydroxysteroid
;dehydrogenase (11 betaHSD) inhibitor carbenoxolone (CBX).
;[950..964]:substance:"corticosterone"
;[973..1010]:substance:"11  beta-hydroxysteroid dehydrogenase"
;[1012..1022]:substance:"11 betaHSD"
;[1024..1033]:substance:"inhibitor"
;[1034..1047]:substance:"carbenoxolone"
;[1049..1052]:substance:"CBX"
(SENT
  (S
    (NP-SBJ-1 (DT:[919..923] This) (NN:[924..932] reaction))
    (VP (VBD:[933..936] was)
      (VP (VBN:[937..946] inhibited)
        (NP-1 (-NONE-:[946..946] *))
        (PP (IN:[947..949] by)
          (NP-LGS
            (NP (NN:[950..964] corticosterone))
            (CC:[965..968] and)
            (NP
              (NP (DT:[969..972] the)
                (NML
                  (NML (CD:[973..975] 11) (NN:[977..996] beta-hydroxysteroid)
                       (NN:[997..1010] dehydrogenase))
                  (NML (-LRB-:[1011..1012] -LRB-)
                     (CD:[1012..1014] 11) (NN:[1015..1022] betaHSD)
                    (-RRB-:[1022..1023] -RRB-)))
                (NN:[1024..1033] inhibitor))
              (NP
                (NP (NN:[1034..1047] carbenoxolone))
                (NP (-LRB-:[1048..1049] -LRB-) (NN:[1049..1052] CBX)
                    (-RRB-:[1052..1053] -RRB-))))))))
    (.:[1053..1054] .)))

;sentence 8 Span:1056..1210
;The conversion of 7 alpha-OH-DHEA to 7-oxo-DHEA by rat kidney occurred at
;higher  rates with NAD(+) than with NADP(+) and was inhibited by
;corticosterone.
;[1074..1089]:substance:"7 alpha-OH-DHEA"
;[1093..1103]:substance:"7-oxo-DHEA"
;[1149..1155]:substance:"NAD(+)"
;[1166..1173]:substance:"NADP(+)"
;[1195..1209]:substance:"corticosterone"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[1056..1059] The) (NN:[1060..1070] conversion))
      (PP (IN:[1071..1073] of)
        (NP (CD:[1074..1075] 7) (NN:[1076..1089] alpha-OH-DHEA)))
      (PP (TO:[1090..1092] to)
        (NP (NN:[1093..1103] 7-oxo-DHEA)))
      (PP (IN:[1104..1106] by)
        (NP (NN:[1107..1110] rat) (NN:[1111..1117] kidney))))
    (VP
      (VP (VBD:[1118..1126] occurred)
        (PP (IN:[1127..1129] at)
          (NP (JJR:[1130..1136] higher) (NNS:[1138..1143] rates)))
        (PP (IN:[1144..1148] with)
          (NP (NN:[1149..1152] NAD) (-LRB-:[1152..1153] -LRB-)
              (SYM:[1153..1154] +) (-RRB-:[1154..1155] -RRB-)))
        (PP (IN:[1156..1160] than)
          (PP (IN:[1161..1165] with)
            (NP (NN:[1166..1170] NADP) (-LRB-:[1170..1171] -LRB-)
                (SYM:[1171..1172] +) (-RRB-:[1172..1173] -RRB-)))))
      (CC:[1174..1177] and)
      (VP (VBD:[1178..1181] was)
        (VP (VBN:[1182..1191] inhibited)
          (NP-1 (-NONE-:[1191..1191] *))
          (PP (IN:[1192..1194] by)
            (NP-LGS (NN:[1195..1209] corticosterone))))))
    (.:[1209..1210] .)))

;sentence 9 Span:1211..1349
;With  NADPH, 7-oxo-DHEA was converted to unidentified hydroxylated
;metabolites and low  levels of 7 alpha-OH-DHEA by rat liver microsomes.
;[1217..1222]:substance:"NADPH"
;[1224..1234]:substance:"7-oxo-DHEA"
;[1278..1289]:substance:"metabolites"
;[1309..1324]:substance:"7 alpha-OH-DHEA"
(SENT
  (S
    (PP (IN:[1211..1215] With)
      (NP (NN:[1217..1222] NADPH)))
    (,:[1222..1223] ,)
    (NP-SBJ-1 (NN:[1224..1234] 7-oxo-DHEA))
    (VP (VBD:[1235..1238] was)
      (VP (VBN:[1239..1248] converted)
        (NP-1 (-NONE-:[1248..1248] *))
        (PP-CLR (TO:[1249..1251] to)
          (NP
            (NP (JJ:[1252..1264] unidentified) (VBN:[1265..1277] hydroxylated)
                (NNS:[1278..1289] metabolites))
            (CC:[1290..1293] and)
            (NP
              (NP (JJ:[1294..1297] low) (NNS:[1299..1305] levels))
              (PP (IN:[1306..1308] of)
                (NP (CD:[1309..1310] 7) (NN:[1311..1324] alpha-OH-DHEA))))))
        (PP (IN:[1325..1327] by)
          (NP-LGS (NN:[1328..1331] rat) (NN:[1332..1337] liver)
                  (NNS:[1338..1348] microsomes)))))
    (.:[1348..1349] .)))

;sentence 10 Span:1350..1524
;In contrast, pig liver  microsomal fractions reduced 7-oxo-DHEA to nearly
;equal amounts of 7 alpha- and  7 beta-OH-DHEA, while human fractions produced
;mainly 7 beta-OH-DHEA.
;[1403..1413]:substance:"7-oxo-DHEA"
;[1441..1449]...[1462..1469]:substance:"7 alpha-"..."OH-DHEA"
;[1455..1469]:substance:"7 beta-OH-DHEA"
;[1509..1523]:substance:"7 beta-OH-DHEA"
(SENT
  (S
    (PP (IN:[1350..1352] In)
      (NP (NN:[1353..1361] contrast)))
    (,:[1361..1362] ,)
    (NP-SBJ (NN:[1363..1366] pig) (NN:[1367..1372] liver)
            (JJ:[1374..1384] microsomal) (NNS:[1385..1394] fractions))
    (VP (VBD:[1395..1402] reduced)
      (NP (NN:[1403..1413] 7-oxo-DHEA))
      (PP-CLR (TO:[1414..1416] to)
        (NP
          (NP
            (ADJP (RB:[1417..1423] nearly) (JJ:[1424..1429] equal))
            (NNS:[1430..1437] amounts))
          (PP (IN:[1438..1440] of)
            (NP
              (NP (CD:[1441..1442] 7) (SYM:[1443..1448] alpha)
                  (HYPH:[1448..1449] -)
                (NML-1 (-NONE-:[1449..1449] *P*)))
              (CC:[1450..1453] and)
              (NP (CD:[1455..1456] 7) (SYM:[1457..1461] beta)
                  (HYPH:[1461..1462] -)
                (NML-1 (NN:[1462..1469] OH-DHEA)))))))
      (,:[1469..1470] ,)
      (SBAR-ADV (IN:[1471..1476] while)
        (S
          (NP-SBJ (JJ:[1477..1482] human) (NNS:[1483..1492] fractions))
          (VP (VBD:[1493..1501] produced)
            (ADVP (RB:[1502..1508] mainly))
            (NP (CD:[1509..1510] 7) (NN:[1511..1523] beta-OH-DHEA))))))
    (.:[1523..1524] .)))

;sentence 11 Span:1526..1693
;Dehydrocorticosterone inhibited the reduction to both isomers by pig liver 
;microsomes, but only to 7 alpha-OH-DHEA by human microsomes; CBX inhibited
;both  reactions.
;[1526..1547]:substance:"Dehydrocorticosterone"
;[1580..1587]:substance:"isomers"
;[1626..1641]:substance:"7 alpha-OH-DHEA"
;[1663..1666]:substance:"CBX"
(SENT
  (S
    (S
      (NP-SBJ (NN:[1526..1547] Dehydrocorticosterone))
      (VP
        (VP (VBD:[1548..1557] inhibited)
          (NP
            (NP (DT:[1558..1561] the) (NN:[1562..1571] reduction))
            (PP=2 (TO:[1572..1574] to)
              (NP (DT:[1575..1579] both) (NNS:[1580..1587] isomers)))
            (PP=3 (IN:[1588..1590] by)
              (NP (NN:[1591..1594] pig) (NN:[1595..1600] liver)
                  (NNS:[1602..1612] microsomes)))))
        (,:[1612..1613] ,) (CC:[1614..1617] but)
        (VP
          (ADVP (RB:[1618..1622] only))
          (NP
            (PP=2 (TO:[1623..1625] to)
              (NP (CD:[1626..1627] 7) (NN:[1628..1641] alpha-OH-DHEA)))
            (PP=3 (IN:[1642..1644] by)
              (NP (JJ:[1645..1650] human) (NNS:[1651..1661] microsomes)))))))
    (::[1661..1662] ;)
    (S
      (NP-SBJ (NN:[1663..1666] CBX))
      (VP (VBD:[1667..1676] inhibited)
        (NP (DT:[1677..1681] both) (NNS:[1683..1692] reactions))))
    (.:[1692..1693] .)))

;sentence 12 Span:1694..1757
;Rat kidney did not reduce 7-oxo-DHEA with either NADPH or NADH.
;[1720..1730]:substance:"7-oxo-DHEA"
;[1743..1748]:substance:"NADPH"
;[1752..1756]:substance:"NADH"
(SENT
  (S
    (NP-SBJ (NN:[1694..1697] Rat) (NN:[1698..1704] kidney))
    (VP (VBD:[1705..1708] did) (RB:[1709..1712] not)
      (VP (VB:[1713..1719] reduce)
        (NP (NN:[1720..1730] 7-oxo-DHEA))
        (PP (IN:[1731..1735] with)
          (NP (CC:[1736..1742] either) (NN:[1743..1748] NADPH)
              (CC:[1749..1751] or) (NN:[1752..1756] NADH)))))
    (.:[1756..1757] .)))

;sentence 13 Span:1758..1914
;These  results demonstrate that DHEA is first converted in liver to 7
;alpha-OH-DHEA,  which is subsequently oxidized to 7-oxo-DHEA in both liver
;and kidney.
;[1790..1794]:substance:"DHEA"
;[1826..1841]:substance:"7 alpha-OH-DHEA"
;[1878..1888]:substance:"7-oxo-DHEA"
(SENT
  (S
    (NP-SBJ (DT:[1758..1763] These) (NNS:[1765..1772] results))
    (VP (VBP:[1773..1784] demonstrate)
      (SBAR (IN:[1785..1789] that)
        (S
          (NP-SBJ (NN:[1790..1794] DHEA))
          (VP (VBZ:[1795..1797] is)
            (ADVP-TMP (RB:[1798..1803] first))
            (VP (VBN:[1804..1813] converted)
              (PP-LOC (IN:[1814..1816] in)
                (NP (NN:[1817..1822] liver)))
              (PP-CLR (TO:[1823..1825] to)
                (NP
                  (NP (CD:[1826..1827] 7) (NN:[1828..1841] alpha-OH-DHEA))
                  (,:[1841..1842] ,)
                  (SBAR
                    (WHNP-1 (WDT:[1844..1849] which))
                    (S
                      (NP-SBJ-1 (-NONE-:[1849..1849] *T*))
                      (VP (VBZ:[1850..1852] is)
                        (ADVP-TMP (RB:[1853..1865] subsequently))
                        (VP (VBN:[1866..1874] oxidized)
                          (PP-CLR (TO:[1875..1877] to)
                            (NP (NN:[1878..1888] 7-oxo-DHEA)))
                          (PP-LOC (IN:[1889..1891] in)
                            (NP (CC:[1892..1896] both) (NN:[1897..1902] liver)
                                (CC:[1903..1906] and) (NN:[1907..1913] kidney))))))))))))))
    (.:[1913..1914] .)))

;sentence 14 Span:1915..2184
;In liver,  interconversion of 7-oxo-DHEA and 7-OH-DHEA isomers is largely
;catalyzed by 11  betaHSD1, while in kidney 11 betaHSD2 (NAD(+)-dependent) and
;11 betaHSD3  (NADP(+)-dependent) likely catalyze the unidirectional oxidation
;of 7  alpha-hydroxy-DHEA to 7-oxo-DHEA.
;[1945..1955]...[1970..1977]:substance:"7-oxo-DHEA"..."isomers"
;[1960..1977]:substance:"7-OH-DHEA isomers"
;[2002..2014]:substance:"11  betaHSD1"
;[2032..2043]:substance:"11 betaHSD2"
;[2045..2051]:substance:"NAD(+)"
;[2067..2078]:substance:"11 betaHSD3"
;[2081..2088]:substance:"NADP(+)"
;[2148..2169]:substance:"7  alpha-hydroxy-DHEA"
;[2173..2183]:substance:"7-oxo-DHEA"
(SENT
  (S
    (PP-LOC (IN:[1915..1917] In)
      (NP (NN:[1918..1923] liver)))
    (,:[1923..1924] ,)
    (NP-SBJ-2
      (NP (NN:[1926..1941] interconversion))
      (PP (IN:[1942..1944] of)
        (NP
          (NP (NN:[1945..1955] 7-oxo-DHEA)
            (NML-1 (-NONE-:[1955..1955] *P*)))
          (CC:[1956..1959] and)
          (NP (NN:[1960..1969] 7-OH-DHEA)
            (NML-1 (NNS:[1970..1977] isomers))))))
    (VP (VBZ:[1978..1980] is)
      (ADVP (RB:[1981..1988] largely))
      (VP (VBN:[1989..1998] catalyzed)
        (NP-2 (-NONE-:[1998..1998] *))
        (PP (IN:[1999..2001] by)
          (NP-LGS (CD:[2002..2004] 11) (NN:[2006..2014] betaHSD1)))
        (,:[2014..2015] ,)
        (SBAR-ADV (IN:[2016..2021] while)
          (S
            (PP-LOC (IN:[2022..2024] in)
              (NP (NN:[2025..2031] kidney)))
            (NP-SBJ
              (NP
                 (CD:[2032..2034] 11) (NN:[2035..2043] betaHSD2)
                (PRN (-LRB-:[2044..2045] -LRB-)
                  (ADJP
                    (NML (NN:[2045..2048] NAD) (-LRB-:[2048..2049] -LRB-)
                         (SYM:[2049..2050] +) (-RRB-:[2050..2051] -RRB-))
                    (HYPH:[2051..2052] -) (JJ:[2052..2061] dependent))
                  (-RRB-:[2061..2062] -RRB-)))
              (CC:[2063..2066] and)
              (NP
                 (CD:[2067..2069] 11) (NN:[2070..2078] betaHSD3)
                (PRN (-LRB-:[2080..2081] -LRB-)
                  (NML (NN:[2081..2085] NADP) (-LRB-:[2085..2086] -LRB-)
                       (SYM:[2086..2087] +) (-RRB-:[2087..2088] -RRB-))
                  (HYPH:[2088..2089] -) (JJ:[2089..2098] dependent)
                   (-RRB-:[2098..2099] -RRB-))))
            (ADVP (RB:[2100..2106] likely))
            (VP (VBP:[2107..2115] catalyze)
              (NP
                (NP (DT:[2116..2119] the) (JJ:[2120..2134] unidirectional)
                    (NN:[2135..2144] oxidation))
                (PP (IN:[2145..2147] of)
                  (NP (CD:[2148..2149] 7) (NN:[2151..2169] alpha-hydroxy-DHEA)))
                (PP (TO:[2170..2172] to)
                  (NP (NN:[2173..2183] 7-oxo-DHEA)))))))))
    (.:[2183..2184] .)))

;sentence 15 Span:2185..2335
;Distinct species-specific routes of metabolism  of DHEA and the
;interconversion of its metabolites obviate extrapolation of  animal studies
;to humans.
;[2236..2240]:substance:"DHEA"
;[2272..2283]:substance:"metabolites"
(SENT
  (S
    (NP-SBJ
      (NP
        (NP (JJ:[2185..2193] Distinct)
          (ADJP (NN:[2194..2201] species) (HYPH:[2201..2202] -)
                (JJ:[2202..2210] specific))
          (NNS:[2211..2217] routes))
        (PP (IN:[2218..2220] of)
          (NP
            (NP (NN:[2221..2231] metabolism))
            (PP (IN:[2233..2235] of)
              (NP (NN:[2236..2240] DHEA))))))
      (CC:[2241..2244] and)
      (NP
        (NP (DT:[2245..2248] the) (NN:[2249..2264] interconversion))
        (PP (IN:[2265..2267] of)
          (NP (PRP$:[2268..2271] its) (NNS:[2272..2283] metabolites)))))
    (VP (VBP:[2284..2291] obviate)
      (NP
        (NP (NN:[2292..2305] extrapolation))
        (PP (IN:[2306..2308] of)
          (NP (NN:[2310..2316] animal) (NNS:[2317..2324] studies)))
        (PP (TO:[2325..2327] to)
          (NP (NNS:[2328..2334] humans)))))
    (.:[2334..2335] .)))

;section 16 Span:2339..2384
;PMID: 12667489 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[2339..2343] PMID) (::[2343..2344] :) (CD:[2345..2353] 12667489)
        (NN:[2354..2355] -LSB-) (NNP:[2355..2361] PubMed) (::[2362..2363] -)
        (NN:[2364..2371] indexed) (IN:[2372..2375] for)
        (NNP:[2376..2384] MEDLINE-RSB-)))
